Show simple item record

dc.creatorAmory, John K.
dc.creatorPage, Stephanie T.
dc.creatorBremner, William J.
dc.creatorAnawalt, Bradley D.
dc.creatorHerbst, Karen L.
dc.creatorCoviello, Andrea D.
dc.date2008-10-17T20:40:52Z
dc.date2008-10-17T20:40:52Z
dc.date2004-12
dc.date.accessioned2012-06-12T05:18:22Z
dc.date.available2012-06-12T05:18:22Z
dc.date.issued2012-06-12
dc.identifierJ Clin Endocrinol Metab. 2004 Dec;89(12):5959-65
dc.identifierhttp://hdl.handle.net/1773/4325
dc.identifier.urihttps://repositorio.leon.uia.mx/xmlui/1773/4325
dc.descriptionAcyline is a novel GnRH antagonist that reliably inhibits gonadotropins and testosterone (T) levels in men for 48 h after a single dose up to 75 microg/kg. In this study we examined gonadotropin and T levels in 28 healthy young men administered acyline as single doses of 150 or 300 microg/kg or serial injections of 75 microg/kg. A single 300 microg/kg dose of acyline suppressed gonadotropins and T to castrate levels for 15 d (baseline, 21.1 +/- 3.1; nadir, 1.95 +/- 0.4 nmol/liter; mean +/- sem; P < 0.05). Serum acyline levels peaked 90 min after the injection of 300 microg/kg acyline to a maximum concentration of 112.4 +/- 18 ng/ml (n = 7; t(1/2) = 4.9 d). Injections of 75 microg/kg acyline every 2 d for five doses suppressed gonadotropins for more than 20 d (nadir T, 1.06 +/- 0.17 nmol/liter; P < 0.05 compared with baseline). Adverse events were mild and included erythema and pruritus at the injection site. Acyline, therefore, is one of the most potent peptide GnRH antagonists studied to date with minimal adverse events. A twice monthly injection of acyline could be used as a potent suppressor of the GnRH axis to advance the development of a hormonal male contraceptive or for treatment of hormonally dependent disease.
dc.languageen_US
dc.publisherEndocrine Society
dc.subjectmale contraception
dc.subject5-alpha reductase inhibitors
dc.subjectandrology
dc.subjectgonadotropins
dc.subjecttestosterone
dc.subjectInjections, Subcutaneous
dc.subjectHumans
dc.subjectMiddle Aged
dc.subjectPruritus, chemically induced
dc.subjectMale
dc.subjectDrug Administration Schedule
dc.subjectTime Factors
dc.subjectReference Values
dc.subjectResearch Support, U.S. Gov't, P.H.S.
dc.subjectOligopeptides, administration & dosage, adverse effects, blood, pharmacokinetics, pharmacology
dc.subjectGonadorelin, antagonists & inhibitors
dc.subjectGonadotropins, antagonists & inhibitors, blood
dc.subjectErythema, chemically induced
dc.subjectTestosterone, antagonists & inhibitors, blood
dc.subjectAdult
dc.titleA single dose of the potent gonadotropin-releasing hormone antagonist acyline suppresses gonadotropins and testosterone for 2 weeks in healthy young men
dc.typeArticle


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record